Emerald Mutual Fund Advisers Trust’s Ionis Pharmaceuticals IONS Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-5,978	Closed	-$359K	–	264
2015 Q1	$359K	Sell	5,978 -134,861	-96%	-$9.15M	0.03%	208
2014 Q4	$8.7M	Sell	140,839 -87,280	-38%	-$4.31M	0.75%	50
2014 Q3	$8.86M	Buy	228,119 +46,280	+25%	+$1.64M	0.85%	45
2014 Q2	$6.26M	Buy	181,839 +26,101	+17%	+$822K	0.58%	67
2014 Q1	$6.73M	Sell	155,738 -222,348	-59%	-$10.8M	0.64%	64
2013 Q4	$16.9M	Buy	378,086 +230,008	+155%	+$8.19M	1.01%	31
2013 Q3	$5.56M	Buy	148,078 +9,440	+7%	+$282K	0.77%	51
2013 Q2	$3.73M	Buy	+138,638	New	+$2.95M	0.63%	61

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's IONS Position: Q2 2015 in Review

Emerald Mutual Fund Advisers Trust sold out of Ionis Pharmaceuticals (IONS) in Q2 2015, closing a stake of 5,978 shares — an estimated $359K sold.

Emerald Mutual Fund Advisers Trust first reported a position in IONS in Q2 2013 and held it in 8 quarters. The position peaked at $16.9M in Q4 2013. 353 funds tracked by Wall St. Rank hold IONS as of Q2 2015.

Emerald Mutual Fund Advisers Trust reported no remaining Ionis Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 5,978 Ionis Pharmaceuticals shares in Q2 2015, an estimated $359K.
Emerald Mutual Fund Advisers Trust first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 8 quarters.
Emerald Mutual Fund Advisers Trust's Ionis Pharmaceuticals position peaked at $16.9M in Q4 2013.
353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2015.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2015, filed 28 Jul 2015.